Approval · Notice of Compliance 9019 · 2007
CIALIS: Notice of Compliance 9019
Issued September 11, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9019
- Date
- September 11, 2007
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Cgmp-specific phosphodiesterase type 5 inhibitor / treatment of erectile dysfunction